BIOCLINEC
ActiveSummary
BIOCLINEC has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €320,025. Equity is growing by about 5% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2018 to 2025net €320,025 ▲2.4%
Net result €320,025, the highest in the series.
04-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
15-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
07-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
07-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Liquidity more than doubledcurrent ratio 5.26
Current ratio from 2.54 to 5.26; short-term debt falls from €722,262 to €287,803.
02-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
29-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-07
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
06-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
04-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.